Leading up to its famed Oscars after-party, Vanity Fair and Saint Laurent teamed to throw a pre-awards dinner hosted by the famed fashion house’s creative director Anthony Vaccarello and VF’s editor ...

Salah's numbers are just ridiculous.

New York State Common Retirement Fund lowered its position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) by 3.6% during the fourth quarter, Holdings Channel.com reports. The fund owned ...

The Rollins College men’s and women’s basketball teams hosted their Senior Night on Wednesday, Feb. 26, in what turned out to ...

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) gapped up prior to trading on Tuesday after the company announced better than expected quarterly earnings. The stock had previously closed ...

周三，古根海姆维持对Tarsus制药（NASDAQ:TARS）的"买入"评级，并将目标价从此前的75美元上调至78美元。这一决定基于该公司第四季度的出色表现。Tarsus制药报告Xdemvy销售额达到6,640万美元，超过了古根海姆和市场预期，第四季度需求强劲，全年销售总额达到1.8亿美元。根据 InvestingPro 数据显示，公司收入增长达948%，并保持93%的高毛利率。公司披露已售出58 ...

周三，尽管Tarsus Pharmaceuticals（NASDAQ:TARS）在发布第四季度财报后股价下跌9.3%，H.C. Wainwright仍重申了该公司的买入评级和73.00美元的目标价。根据InvestingPro数据显示，TARS在过去一周下跌16.67%，基于公允价值分析，目前股价显示被低估。H.C.

Barclays lowered the firm’s price target on Tarsus Pharmaceuticals (TARS) to $60 from $62 and keeps an Overweight rating on the shares ...

Tarsus Pharmaceuticals Inc (TARS) reports robust sales and strategic advancements, despite high operating expenses and market ...

Good morning, and welcome to Tarsus Year End 2024 Financial Results Conference Call. As a reminder, this call is being recorded. At this time, I would like to turn the call over to David Nakasone, ...

Tarsus Pharmaceuticals (TARS) delivered earnings and revenue surprises of 11.76% and 12.33%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the ...

Barclays analyst Balaji Prasad maintained a Buy rating on Tarsus Pharmaceuticals (TARS – Research Report) today and set a price target of ...